Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 15 studies | 24% ± 8% | |
| oligodendrocyte | 11 studies | 32% ± 12% | |
| capillary endothelial cell | 3 studies | 21% ± 4% | |
| glomerular endothelial cell | 3 studies | 25% ± 3% | |
| endothelial cell of artery | 3 studies | 23% ± 5% | |
| epithelial cell | 3 studies | 27% ± 9% | |
| ciliated cell | 3 studies | 24% ± 10% | |
| oligodendrocyte precursor cell | 3 studies | 27% ± 6% | |
| basal cell | 3 studies | 21% ± 2% |
Insufficient scRNA-seq data for expression of CPNE2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 100% | 2879.40 | 2637 / 2642 | 100% | 62.22 | 704 / 705 |
| ovary | 100% | 1378.96 | 180 / 180 | 98% | 28.39 | 423 / 430 |
| intestine | 100% | 3108.01 | 966 / 966 | 98% | 21.64 | 516 / 527 |
| lung | 100% | 3987.49 | 578 / 578 | 98% | 23.03 | 1128 / 1155 |
| uterus | 100% | 2600.78 | 170 / 170 | 97% | 23.27 | 444 / 459 |
| skin | 100% | 1492.21 | 1802 / 1809 | 97% | 19.28 | 457 / 472 |
| thymus | 100% | 2337.73 | 653 / 653 | 96% | 18.30 | 580 / 605 |
| kidney | 99% | 1841.74 | 88 / 89 | 96% | 21.33 | 863 / 901 |
| breast | 100% | 3274.37 | 459 / 459 | 94% | 12.53 | 1051 / 1118 |
| esophagus | 100% | 1993.70 | 1445 / 1445 | 94% | 18.42 | 172 / 183 |
| prostate | 100% | 2123.62 | 245 / 245 | 92% | 13.53 | 463 / 502 |
| bladder | 100% | 2054.24 | 21 / 21 | 91% | 15.92 | 457 / 504 |
| stomach | 85% | 969.63 | 306 / 359 | 95% | 17.93 | 272 / 286 |
| adrenal gland | 96% | 984.66 | 247 / 258 | 76% | 10.14 | 175 / 230 |
| pancreas | 68% | 492.19 | 224 / 328 | 95% | 12.86 | 169 / 178 |
| liver | 53% | 387.07 | 119 / 226 | 61% | 6.25 | 246 / 406 |
| adipose | 100% | 3935.83 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| spleen | 100% | 2762.96 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 19.07 | 45 / 45 |
| blood vessel | 100% | 2246.50 | 1332 / 1335 | 0% | 0 | 0 / 0 |
| heart | 96% | 1100.28 | 828 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 95% | 14.96 | 76 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 93% | 15.63 | 27 / 29 |
| muscle | 91% | 888.24 | 729 / 803 | 0% | 0 | 0 / 0 |
| peripheral blood | 82% | 1420.05 | 764 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0071277 | Biological process | cellular response to calcium ion |
| GO_0070062 | Cellular component | extracellular exosome |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005634 | Cellular component | nucleus |
| GO_0005544 | Molecular function | calcium-dependent phospholipid binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0046872 | Molecular function | metal ion binding |
| Gene name | CPNE2 |
| Protein name | Copine 2 Copine-2 (Copine II) |
| Synonyms | |
| Description | FUNCTION: Calcium-dependent phospholipid-binding protein that plays a role in calcium-mediated intracellular processes. Exhibits calcium-dependent cell membrane binding properties. . |
| Accessions | ENST00000567487.1 H3BUC8 H3BQQ3 ENST00000566259.1 ENST00000565874.5 [Q96FN4-1] ENST00000565766.1 H3BPR8 ENST00000290776.13 [Q96FN4-1] ENST00000535318.6 [Q96FN4-1] Q96FN4 |
